Table I.

Patient Characteristics (n=17)^*

Age, years (median; range)	71 (18–88)
Sex (male; %)	8 (47)
Histology (n; %)
PTCL-NOS	7 (41)
FTL	4 (18)
tMF	3 (18)
Other†	3 (23)
Number of prior therapies (median; range)	2 (1–9)
>2 prior therapies (n; %)	6 (35)
Refractory to last therapy (%)‡	11 (65)

Abbreviations: PTCL-NOS, peripheral T-cell lymphoma, not otherwise specified; FTL, follicular T-cell lymphoma (includes angioimmunoblastic T-cell lymphoma); tMF, transformed mycosis fungoides.

^*Patient with ineligible histology not included

^†“Other” includes monomorphic epitheliotropic T-cell lymphoma, hepatosplenic T-cell lymphoma, Alk-negative anaplastic large cell lymphoma (n=1 each)

^‡defined as either not responding to or relapse within 3 months of prior therapy